E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 8/11/2017 in the Prospect News Emerging Markets Daily.

New Issue: India’s Piramal approves Rs. 750 million of 7.9% three-year debentures

By Wendy Van Sickle

Columbus, Ohio, Aug. 11 – Piramal Enterprises Ltd. informed the Bombay Stock Exchange that its board of directors approved the allotment of up to Rs. 750 million of 7.9% secured nonconvertible debentures on Friday.

There is an up to Rs. 3 billion oversubscription option. The securities have a tenor of 1,096 days.

The debentures will be issued on a private placement basis and will be listed on the wholesale debt market segment of the National Stock Exchange of India Ltd.

Piramal Enterprises, formerly Piramal Healthcare Ltd., is a Mumbai-based subsidiary of the Piramal Group.

Issuer:Piramal Enterprises Ltd.
Issue:Secured nonconvertible debentures
Amount:Rs. 750 million
Greenshoe:Rs. 3 billion.
Tenor:1,096 days
Coupon:7.9%
Pricing date:Aug. 11

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.